Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.30 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20607798 | 0.82 | DGAT1 (0.48) | DGAT1HTR2BTMEM97SIGMAR1MAOA | |
| SCHEMBL19647535 | 0.79 | MAPT (0.36) | MCHR1MAOAMAOB | |
| SCHEMBL13035523 | 0.79 | DGAT1 (0.43) | DGAT1HTR2BTMEM97SIGMAR1MAOA | |
| SCHEMBL19647565 | 0.78 | SNCA (0.32) | SNCA | |
| SCHEMBL3445787 | 0.78 | DGAT1 (0.40) | DGAT1HTR2BTMEM97SIGMAR1MAOA | |
| SCHEMBL1135226 | 0.77 | MAOB (0.46) | DGAT1HTR2BTMEM97SIGMAR1MAOA | |
| SCHEMBL3446635 | 0.76 | DGAT1 (0.40) | DGAT1HTR2BTMEM97SIGMAR1MAOA | |
| SCHEMBL1135188 | 0.75 | ERN1 (0.40) | MAOAMAOB | |
| SCHEMBL19519621 | 0.75 | DGAT1 (0.37) | DGAT1MAOB | |
| SCHEMBL24266097 | 0.74 | LIPE (0.40) | SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180016285-A1 | Boron-Containing Small Molecules | ANACOR PHARMACEUTICALS, LLC | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180016285-A1 | Boron-Containing Small Molecules | BCL6B, BLVRB, BCL6 | DGAT1 3618/4885HTR2B 4714/4885TMEM97 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.